About: Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection
Creator	Zhang, Bo Zhang, Xufeng Zeng, Yong Yi, Cunjian
Source	Medline; PMC
abstract	In December 2019, a cluster of pneumonia cases was caused by the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China. Cancer patients are a special group, the immunity of them will be suppressed because of various anti-tumor treatments, and the risk of infection will be greatly increased, so we will report clinical features of 9 cancer patients with SARS-CoV-2 infection. 5 (56%) patients were ordinary type, 3 (33%) were severe type, and 1 (11%) was critical type. A total of 8 patients received combined therapy of traditional Chinese medicines and western medicines. From the clinical outcomes of these 8 patients, western combined therapy of traditional Chinese medicine was indeed an effective treatment method. D-dimmer rise, infection index rise, and chest CT(computed tomography) progression may be clinical warning indicators for severe patients, in our study, more 50% of patients had elevated levels of these indicators, but only 44% (including the dead) of patients had received treatment in the intensive care unit. 5 (56%) ordinary type patients had been discharged, while the 1 (11%) critical type patient died 3 days after admission. Cancer comorbidity seems to have no direct relationship with severe events, and the combination of traditional Chinese medicine and western medicine may be effective in the prevention and treatment of novel coronavirus-infected pneumonia (NICP).
has issue date	2020-05-14(xsd:dateTime)
bibo:doi	10.1186/s13020-020-00328-8
bibo:pmid	32435272
has license	cc-by
sha1sum (hex)	f8cf8f55264b57cc6f940a5e14429bba387584ee
schema:url	https://doi.org/10.1186/s13020-020-00328-8
resource representing a document's title	Clinical characteristics of 9 cancer patients with SARS-CoV-2 infection
has PubMed Central identifier	PMC7224342
has PubMed identifier	32435272
schema:publication	Chin Med
resource representing a document's body	covid:f8cf8f55264b57cc6f940a5e14429bba387584ee#body_text
is schema:about of	named entity 'computed tomography' named entity 'pneumonia' named entity 'Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2)' named entity 'chest' named entity 'progression' named entity 'therapy' named entity 'prevention' named entity 'infection' named entity 'indicators' named entity 'infection' named entity 'CAUSED BY' named entity 'RISK OF INFECTION' named entity 'DEAD' named entity 'ADMISSION' named entity 'PROGRESSION' named entity 'SEVERE' covid:arg/f8cf8f55264b57cc6f940a5e14429bba387584ee named entity 'traditional Chinese medicines' named entity 'Wuhan' named entity 'severe' named entity 'type' named entity 'patients' named entity 'SARS-CoV-2' named entity 'admission' named entity 'study' named entity 'patients' named entity 'Cancer' named entity 'patient' named entity 'pneumonia' named entity 'infection' named entity 'indicators' named entity 'received' named entity 'total' named entity 'Wuhan' named entity 'infection' named entity 'Severe Acute Respiratory Syndrome coronavirus 2' named entity 'comorbidity' named entity 'pneumonia' named entity 'SARS-CoV-2' named entity 'western medicine' named entity 'pneumonia' named entity 'traditional Chinese medicine' named entity 'treatment group' named entity 'life support' named entity 'intensive care unit' named entity 'patients' medical records' named entity 'antibiotic treatments' named entity 'antiviral treatment' named entity 'SARS-CoV-2' named entity 'clinical features' named entity 'oxygen' named entity 'intravenous' named entity 'infection' named entity 'SARS-CoV-2' named entity 'oxygen' named entity 'intravenous' named entity 'international public health emergency' named entity 'SARS-CoV-2' named entity 'ground-glass opacity' named entity 'infection' named entity 'cough' named entity 'traditional Chinese medicines' named entity 'Lung' named entity 'treatment protocol' named entity 'plague' named entity 'antibiotics' named entity 'lung' named entity 'antitumor' named entity 'pneumonia' named entity 'comorbidity' named entity 'SARS-CoV-2' named entity 'medical imaging' named entity 'cure rate' named entity 'NCIP' named entity 'National Health Commission' named entity 'critical stage' named entity 'Chinese medicine' named entity 'infection'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software